Clinical Study

Nrg-Bn001

Posted Date: May 15, 2019

  • Investigator: Jordan Kharofa
  • Specialties: Cancer, Oncology
  • Type of Study: Drug

The purpose of this study is to compare a different radiation therapy schedule and higher radiation dose to the standard dose of radiation therapy. All patients will receive usual chemotherapy, temozolomide.

Criteria:

To Be Eligible For This Study, Must Have A Diagnosed Glioblastoma Tumor, Age 18 Or Older, Nonpregnant/Nonbreastfeeding, No Prior Invasive Malignancy For 3 Years Minimum, No Severe, Active Comorbidities.

Keywords:

Brain Cancer, Glioblastoma, Tumor, Glioblastoma, Nrg-Bn001

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.